Keywords: files, risperdal, consta, new, data, fda, johnson

J&J files Risperdal Consta new data with FDA

Article | 05 May 2003

Print This

Johnson & Johnson has submitted additional data and analyses to the USFood and Drug Administration in response to the not-approvable notice ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in